Germline PRKACA amplification causes variable phenotypes that may depend on the extent of the genomic defect: molecular mechanisms and clinical presentations.
Maya B Lodish, Bo Yuan, Isaac Levy...
https://pubmed.ncbi.nlm.nih.gov/25924874/Actively Recruiting
Led by Bispebjerg Hospital · Updated on 2026-09-03
50
Participants Needed
1
Research Sites
19 weeks
Total Duration
Researchers are evaluating the time efficiency and practical usability of three non-invasive skin imaging tools in adults with basal cell carcinoma BCC, the most common type of skin cancer. The study aims to determine how long each scan takes, how comfortable the scans are for participants, and how well each imaging tool works across different body areas. This observational study compares optical coherence tomography OCT, line-field confocal optical coherence tomography LC-OCT, and high-frequency ultrasound HFUS using artificial intelligence AI assistance. Participants undergo a single study visit lasting about 40 minutes, during which three sequential non-invasive scans are performed on the skin lesion using the three AI-assisted imaging devices. These devices are CE-marked medical tools used within their approved purposes. No biopsies or treatments are performed as part of the study. The imaging results assist clinical decision-making but do not influence standard care, which proceeds independently. During the visit, participants receive clinical photography, dermoscopic examination, and all three imaging scans, followed by a short questionnaire about their experience. Clinicians also complete forms recording scan times, image quality, AI outputs, and practical feasibility. The study measures time consumption per imaging modality, participant discomfort, and image quality across different body regions. Histological data from routine care biopsies are collected later to compare with imaging findings. Data are securely stored, and participation lasts for the duration of the single visit.
CONDITIONS
Multimodal Imaging of Basal Cell Carcinoma: A Usability Study
O
Otto Dideriksen, MD
E
Emilie Ravn, Project Nurse
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Bispebjerg Hospital
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Approximately 40 minutes per lesion
Participants attend a single visit where three sequential non-invasive skin scans are performed using AI-assisted imaging devices on the lesion. They complete a questionnaire about their experience and clinicians record imaging details. No biopsies or treatments are performed as part of the study.
1 visit (in-person)
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Maya B Lodish, Bo Yuan, Isaac Levy...
https://pubmed.ncbi.nlm.nih.gov/25924874/Tika R Kafle, Bhupal Kattel, Samuel D Lane...
https://pubmed.ncbi.nlm.nih.gov/28985468/Charlotte Gust, Sandra Schuh, Julia Welzel...
https://pubmed.ncbi.nlm.nih.gov/35205830/Shi-Qi Wang, Jie Liu, Qing-Li Zhu...
https://pubmed.ncbi.nlm.nih.gov/31460903/Szabolcs Bozsányi, Mehdi Boostani, Klára Farkas...
https://pubmed.ncbi.nlm.nih.gov/37959375/Jing Qin, Juncheng Wang, Qingli Zhu...
https://pubmed.ncbi.nlm.nih.gov/33638227/Fieke Adan, Patty J Nelemans, Brigitte A B Essers...
https://pubmed.ncbi.nlm.nih.gov/35835136/Ximena Wortsman
https://pubmed.ncbi.nlm.nih.gov/39409920/Waseem Jerjes, Zaid Hamdoon, Dara Rashed...
https://pubmed.ncbi.nlm.nih.gov/39941619/Sébastien Fischman, Théo Viel, Jean-Luc Perrot...
https://pubmed.ncbi.nlm.nih.gov/41109970/Bispebjerg Hospital
Lead Sponsor